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Abstract 
Background: Guidelines recommend that health professionals identify and manage individuals at 
high risk of developing melanoma, but there is limited population-based evidence demonstrating 
real-world practices. 
Aim: To determine doctors’ knowledge of melanoma patients’ risk and to identify factors associated 
with better identification and clinical management. 
Design and Setting: A population-based, observational study conducted in the state of New South 
Wales, Australia.  
Method: Data were analysed from 1,889 people with invasive, localised melanoma from the 
Melanoma Patterns of Care study, which collected data on all melanoma diagnoses notified to the 
state’s cancer registry during a 12-month period from 23 October 2006, as well as questionnaire data 
from the doctors involved in their care.  
Results: Three-quarters (74%) of patients had doctors who were aware of their risk factor status 
regarding personal and family history of melanoma and the presence of many moles. Doctors 
working in general practice, skin cancer clinics and dermatology settings had better knowledge of 
patients’ risk factors than plastic surgeons. Doctors were 15% more likely to know the family history 
for younger melanoma patients (<40 years) than those ≥ 80 years (95% confidence interval 1.04-
1.26). Skin-related follow-up advice was more likely to be given to younger patients, by doctors 
aware of their patients’ risk status, by doctors practising in plastic surgery, dermatology and skin 
cancer clinic settings, and by female doctors. 
Conclusion: Both patient-related and doctor-related factors were associated with doctors’ 
recognition and management of melanoma patients’ risk, and could be the focus of new strategies 
for improving care.   
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How this fits in 
Clinical practice guidelines recommend that health professionals identify patients at high risk of 
developing melanoma and encourage appropriate skin surveillance, to improve earlier detection and 
prognosis. However, there is limited population-based evidence demonstrating real-world practices. 
This large, population-based study provides a snapshot of melanoma care relating to doctors’ 
knowledge of patients’ melanoma risk factors and subsequent skin-related follow-up advice and 
recommendations. We identified patient-related and doctor-related factors associated with better 
identification and follow-up of high-risk patients, thus giving doctors involved in melanoma 
management potential avenues for improving patient care.  
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Introduction 
Melanoma continues to be a significant health issue worldwide, particularly in Australia which has 
one of the highest incidence rates (1). In the most populous Australian state of New South Wales 
(NSW) it is the fourth most common cancer, with 3,705 new cases of invasive cutaneous melanoma 
reported in 2009 (2), and 5,708 new cases annually expected by 2021 (3).  
Internationally, clinical practice guidelines consistently recommend that clinicians should identify 
individuals at high risk of developing melanoma and manage them appropriately to optimise the 
prognosis and health outcomes for patients (4-9). Australian guidelines published in 1999 (10), and 
updated in 2008 (9), outlined risk factors for melanoma, including pigmentation characteristics, 
personal and family history of melanoma, and number of naevi, and recommended that clinicians 
assess their patients for these factors. The guidelines recommended that patients classified as high 
risk should be encouraged to perform skin self-examination, be educated about specific changes that 
suggest melanoma, and be offered a skin surveillance program. This advice is particularly relevant to 
people already diagnosed with melanoma, who are at 5- to 10-fold increased risk of a subsequent 
primary melanoma (11, 12). Targeted high-risk screening and surveillance programs have been 
shown to assist with early diagnosis of melanoma and are deemed more cost-effective than a 
population-wide screening program (13-15). 
Several studies have described different aspects of melanoma management in Australia (16-23), but 
few have compared real-world clinical practice with what is recommended in the guidelines. To 
address this gap, we undertook a survey to evaluate clinicians’ knowledge and management of risk 
factors for people residing in NSW with a diagnosis of melanoma notified to the NSW Cancer Registry 
during a 12-month period in 2006-07. Using these data, we aimed to: 1) determine doctors’ 
knowledge of their patients’ melanoma risk; and 2) identify factors associated with doctors’ 
recognition and subsequent management of patients’ melanoma risk, particularly related to skin self-
examination and surveillance for early detection of future melanomas. 
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Method 
Study design and population 
The Melanoma Patterns of Care Study was a population-based, observational study. It was based on 
doctors’ reported clinical management of NSW residents of any age who had a pathologically-
confirmed primary in situ or invasive cutaneous, or a melanoma of unknown primary site, notified to 
the NSW Cancer Registry between 23 October 2006 and 22 October 2007. Melanomas were classified 
based on ICD-O-3 (International Classification of Diseases for Oncology, 3rd edition) codes C44.0 to 
C44.9 or C80.9 and histology codes 8720-8790 /2 (in situ) or /3 (invasive) (24). The study was 
conducted at the NSW Cancer Registry located within the Cancer Institute NSW, with ethics approval 
from The University of Sydney Human Research Ethics Committee and the NSW Population and 
Health Services Research Ethics Committee. 
Data collection  
Information was collected from the NSW Cancer Registry on the characteristics of the patients, their 
lesions, and the doctors involved in their care. For each eligible patient, the primary doctor was 
contacted by the study team and asked to complete a questionnaire regarding the clinical 
management of that patient. The ‘primary doctor’ for this study was defined as the requesting doctor 
on the diagnostic pathology report on which the cancer registration was based, and was considered 
to be the doctor providing initial care following diagnosis. If the primary doctor referred the patient 
to other doctors (known as referral doctors in this study), they were then also contacted by the study 
team and asked to complete a questionnaire. This process was followed for all notifications of 
eligible invasive melanomas but for only the first 450 notifications of in situ melanomas, in order to 
focus the limited capacity and resources of the research team on the collection of data for invasive 
melanomas. For doctors with large numbers of eligible patients, if requested, trained field workers 
with nursing experience completed the questionnaires from patient medical records. Seventy-two 
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percent of patients had at least one returned questionnaire; the questionnaire completion rate was 
78%; 53% completed by doctors and 25% by trained field workers. 
Questions about doctors’ knowledge of their patients’ risk and subsequent clinical management 
regarding skin surveillance are shown in Table 1. We created a ‘patient risk’ variable based on three 
important risk factors: multiple primary melanomas (i.e. a previous melanoma before the study 
period), family history of melanoma, and having many moles. Patients without any of these risk 
factors were placed in the ‘average-risk’ category; those with at least one reported risk factor were 
placed in the ‘high risk’ category and those whose risk factors were not known were categorised as 
‘no knowledge’. 
We used postcode to estimate the relative remoteness, accessibility and socio-economic 
disadvantage of patients’ place of residence and doctors’ practice location. Postcodes were linked to 
classification systems endorsed by the Australian Government, including Rural Remote and 
Metropolitan Areas (RRMA) (25), Accessibility/Remoteness Index of Australia (ARIA) (26), and the 
Socio-Economic Indexes for Areas (SEIFA) (27).  
Statistical analysis 
This analysis focused on patients with invasive, localised melanoma and thus excluded in situ or 
metastatic melanoma. We also excluded questionnaires completed by trained field workers because 
of the high proportion of unrecorded information in the medical records for the variables related to 
doctors’ knowledge of the presence of risk factors and skin-related follow-up. For 1.2% of patients 
with more than one diagnosis of invasive melanoma during the 12-month period, we included data 
related to the first invasive lesion only, as associations may have been different for subsequent 
melanomas. 
 To examine the factors associated with doctors’ knowledge of patients’ risk factors for melanoma 
and doctors’ management of patients regarding skin-related follow-up advice and recommendations, 
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probability ratios (PR) and 95% confidence intervals (CI) were estimated using log binomial regression 
models. Multivariate models were fitted using a forward stepwise approach with a cut-off p-value of 
0.10. All statistical models included patient age and gender; and models of patient management 
included the patient risk variable, regardless of statistical significance, as they were considered a 
priori as important covariates. Other factors assessed for inclusion were patients’ and doctors’ socio-
demographic characteristics, doctors’ specialty and practice setting, and histopathological features of 
the melanoma. Questionnaires with missing values for these variables were excluded from the 
multivariate analysis. Analysis was conducted using SAS software version 9.4 (28). 
Results 
Patient and lesion characteristics 
 
A total of 1,889 patients with invasive, localised melanoma met the criteria for analysis. Patient and 
melanoma characteristics are presented in Table 2. The majority (61%) were male and 69% lived in 
metropolitan areas. Patients tended to live in areas of relative socio-economic advantage (70% in 
mid to high socio-economic areas) compared to the general population. Superficial spreading 
melanoma was the most common melanoma subtype, and most lesions were located on the trunk 
(36%) and arms (27%). Two-thirds (69%) of the melanomas were ≤ 1 mm thick. 
Characteristics of doctors who returned a questionnaire 
 
Doctors completed 2,190 questionnaires for the 1,889 patients in this analysis; 86% were completed 
by the primary (initial) doctor. Most questionnaires were received from general practitioners (53%), 
dermatologists (24%) and surgeons (18%). Doctors came from the following practice settings: general 
practice (38%); dermatology (23%); surgery (17%); skin cancer clinic (15%); plastic surgery (6%); and 
melanoma unit (1%). Most doctors were male (85%), with 35% and 36% in 45-54 and 55-64 year age 
groups, respectively. Their practices were mainly located in capital cities (50%).   
Doctors’ knowledge of patients’ risk factors for melanoma 
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Table 3 shows that 74% of patients had at least one doctor who was aware of their risk factor status 
regarding personal and family history of melanoma and the presence of many moles, and 1% had 
doctors with no knowledge of the patients’ risk factor status for all three risk factors. Doctors were 
more aware of patients’ personal history of melanoma than family history or number of moles.  
Factors associated with doctors’ knowledge of patients’ risk factors for melanoma 
 
In a multivariate model, patients’ age, and doctors’ specialty, practice setting and whether they were 
the primary or referral doctor, were associated with doctors’ knowledge of risk factors (Table 4). 
Compared to general practitioners, surgeons were less likely to know their patients’ personal history 
of melanoma.  
Doctors were 15% more likely (95% CI 4-26%) to know the family history for younger melanoma 
patients (<40 years) than for those ≥ 80 years. Compared to doctors in a general practice setting, 
those practising in skin cancer clinics were 22% more likely (95% CI 15-29%) to know their patients’ 
family history of melanoma, whereas doctors in a plastic surgery setting were 20% less likely (95% CI 
7-32%) to know their patients’ family history of melanoma. 
Doctors were less likely to know whether or not a patient had many moles if they worked in surgery, 
plastic surgery or melanoma unit practice settings, compared to a general practice setting. Referral 
doctors were 7% less likely to know about patients’ moles compared to primary doctors. 
Although some of the clinician variables were correlated, the variables retained in the multivariate 
models were independently predictive of the outcome. In addition, we examined whether there was 
evidence of interaction between doctors’ gender and practice setting, but found none (p-values 
>0.30). 
Factors associated with doctors’ management of patients regarding skin-related follow-up advice 
and recommendations 
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Overall, 84% of patients were given advice on specific changes that suggest melanoma, 79% were 
encouraged to perform skin self-examination, and 73% were recommended a skin surveillance 
program. 
In a multivariate model, doctors were more likely to give advice on skin changes, encourage skin self-
examination and recommend skin surveillance if they were aware of their patients’ risk status, and if 
they worked in skin cancer clinics, dermatology or plastic surgery settings, compared to general 
practice and melanoma unit settings (Table 5). Doctors were more likely to give advice on skin 
changes and encourage skin self-examination if patients were younger than 80 years old compared 
to ≥ 80 years. A skin surveillance program was 8% more likely (95% CI 2-14%) to be recommended to 
patients by female doctors than by male doctors. There was a marginally statistically significant 
association between higher Breslow thickness and less encouragement for skin self-examination and 
skin surveillance (P=0.06). There was evidence suggesting that patients who lived in certain rural and 
remote areas may be less likely to receive a recommendation for skin surveillance from their doctor 
(P=0.10). 
 
Discussion 
Summary 
This study provides population-based data on doctors’ recognition and management of patients’ 
melanoma risk. Current international and Australian clinical practice guidelines recommend the 
assessment of melanoma-related risk factors by clinicians (4-9). Our study showed that NSW doctors 
were reasonably knowledgeable about patients’ personal and family history of melanoma and 
whether they had many moles. For 74% of patients, their doctor/s knew of all three risk factors, with 
family history being the least known. Doctors’ knowledge of these risk factors was influenced by 
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patient age, doctors’ specialty and practice setting, and whether it was the primary or referral 
doctor. 
General practitioners and doctors practising within skin cancer clinics (typically staffed by general 
practitioners in Australia (22)) and in dermatology settings had better knowledge of patients’ risk 
factors compared to those in plastic surgery and melanoma unit settings. Our findings may reflect 
the accepted role and established procedures for general practitioners and dermatologists to 
optimise the prevention and early detection of melanoma. Other specialists, such as those in plastic 
surgery and melanoma unit settings, may have a more technical or procedure-specific role, e.g. initial 
surgical management, in which knowledge of patients’ risk factors may be less relevant. 
Our findings indicate that doctors largely provided the recommended skin-related advice for 
patients, but adherence to the guidelines was influenced by the patients’ age, doctors’ knowledge of 
their patients’ risk status, practice setting, doctors’ gender, and to a lesser degree, melanoma 
thickness. Doctors were more likely to give appropriate skin-related follow-up advice if they knew of 
their patients’ risk status; but curiously, there was no difference in follow-up advice by whether or 
not the patients had additional risk factors.  
 
Strengths and limitations 
Strengths of this study include the population-based design, large sample size, and a high 
questionnaire completion rate. We sought to collect information from all doctors involved in the 
patients’ care, to give a comprehensive picture of the patterns of care. A potential limitation is the 
exclusion of questionnaires completed by trained field workers from our analysis, because of the 
missing data relating to risk factor information available from patients’ medical notes. Field worker 
assistance was more likely to occur for doctors with a high-volume of melanoma patients, e.g. 
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surgeons. In addition, response bias may have been present due to the self-reported nature of the 
data.  
Comparison with existing literature 
Several studies have described aspects of melanoma care in the Australian setting (18, 19, 22, 29-32), 
or have measured compliance with clinical practice guidelines (21, 33-36). However, to our 
knowledge our study is the first to report on doctors’ knowledge of patients’ risk factors and its 
relationship with subsequent skin-related follow-up advice and recommendations for melanoma in 
Australia. Courtney et al examined similar issues for colorectal cancer, but based on patients’ 
perspectives using a community survey in NSW (37). They found that only 38% of respondents had 
ever been asked if they had a family history of colorectal cancer and only 31% of respondents had 
ever received screening advice from a health care provider; which is less favourable than in our 
study. Langlands et al (38) conducted an audit of 300 hospital patients’ medical records, and found 
that 74% had no details on family history of medical conditions recorded. Similar to our study, 
Langlands et al also reported a trend towards better family history documentation for younger 
patients. 
Our findings add to the growing evidence that older people are less likely to receive care in 
accordance with recommended guidelines, and that age-related disparities in melanoma care exist 
for melanoma prevention and treatment (39, 40). 
Our finding that female doctors were more likely than male doctors to recommend a skin 
surveillance program was similar to that of Markova et al, who found that female physicians were 
more likely to perform skin examinations and were more active in discussing skin self-examination 
than male physicians (41).  
Implications for research and/or practice 
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Our findings suggest that increasing doctors’ awareness of patients’ risk factors for melanoma could 
be one way of improving adherence to clinical practice guidelines regarding skin-related advice and 
follow-up. Family history was the least known risk factor, and obtaining this information from 
patients could be improved by using a validated family history screening questionnaire (42). Various 
risk assessment tools have also been developed for doctors and are widely available (43, 44). Within 
busy practice settings, systematic routine assessment, recording, updating and electronic display of 
patients’ risk factor information may assist this process. Risk factor information should also be 
routinely communicated to other treating doctors.  
Future educational and training programs for doctors should address the age-related disparities in 
melanoma care (39) and potential barriers (45) to improving patient outcomes. Further research into 
age-related disparities in care from the perspectives of the doctor and the patient would be valuable. 
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Tables 
Table 1. Questions for doctors regarding their patients’ risk factors and skin-related follow-up  
Questions regarding risk factors 
Did the patient have a: 
Personal history of melanoma? No, Yes, Don’t know 
Family history of melanoma in a blood relative? No, Yes, Don’t know 
Did this patient have lots of moles? No, Yes, Don’t know 
Questions regarding skin-related follow-up 
Did you do any of the following? 
Advise patient on specific changes that suggest melanoma? Yes, No 
Encourage patient to perform skin self-examination? Yes, No 
Recommend a skin surveillance program? Yes, No 
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Table 2. Patients’ socio-demographic and melanoma characteristics 
Characteristic 
Na 
1,889 
patients 
% 
Patient characteristics   
Age at diagnosis (years)   
<40 167 9 
40-59 551 29 
60-79 855 45 
≥ 80 316 17 
Gender   
Males 1,151 61 
Females 738 39 
Level of socio-economic disadvantageb   
1st quintile (most disadvantaged) 204 11 
2nd quintile 364 19 
3rd quintile 505 27 
4th quintile 321 17 
5th quintile (least disadvantaged) 494 26 
Location of residencec   
Capital city 953 50 
Other metropolitan 359 19 
Large rural 122 6 
Small rural 189 10 
Other rural/remote 265 15 
   
Melanoma characteristics   
Histology   
Superficial spreading melanoma 969 51 
Nodular melanoma 230 12 
Lentigo maligna melanoma 191 10 
Other subtype 67 4 
Not otherwise specified 432 23 
Site   
Head & neck 326 17 
Trunk 683 36 
Arms 506 27 
Legs 360 19 
Not otherwise specified 14 1 
Breslow thickness (mm)   
0.01-1.00 1,293 69 
1.01-2.00 323 17 
2.01-4.00 169 9 
>4.00 94 5 
a One value was missing for level of socio-economic disadvantage and location of residence, and 10 values were missing for 
Breslow thickness. 
b Level of socio-economic disadvantage was based on postcode of residence, linked to the Socio-Economic Indexes for Areas 
(SEIFA) (27). 
c Location of residence was categorised according to the Rural Remote and Metropolitan Areas (RRMA) Classification (25).    
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Table 3. Knowledge of patients’ risk factors by their treating doctor/s, grouped by patienta 
Risk factor N 1,889 patients % 
Personal history   
Unknown 55 3 
Knownb 1,834 97 
Family history   
Unknown 402 21 
Knownb 1,487 79 
Lots of moles   
Unknown 148 8 
Knownb 1,741 92 
Total risk factors known   
0 27 1 
1 68 4 
2 388 21 
3 1,406 74 
a As patients may have had more than one doctor involved in their care, doctors’ responses were combined for each 
patient, so that patients were classified as having a risk factor or relevant follow-up recommendations if any of the doctors 
involved in their care reported this on a questionnaire. 
b Known status refers to the presence or absence of risk factors: personal history of melanoma, family history of melanoma 
in a blood relative and lots of moles. 
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Table 4. Multivariate model of factors associated with doctors’ knowledge of patients’ risk factors for melanoma  
Factors in 
order of entry 
Known personal history of melanoma 
(n=2,164 questionnairesa)  
Known family history of melanoma 
(n=2,190 questionnairesa)  
Known mole status 
(n=2,190 questionnairesa) 
No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec 
Patient age, yearsd                  
<40 4 184 1.03 (0.97-1.09)   35 154 1.15 (1.04-1.26)   26 163 0.96 (0.91-1.02)  
40-59 21 619 1.01 (0.99-1.04)   119 529 1.10 (1.02-1.19)   65 583 0.99 (0.95-1.02)  
60-79 43 927 1.00 (0.98-1.03)   263 722 1.03 (0.95-1.11)   100 885 0.97 (0.94-1.01)  
80+ 18 348 Referent  0.56  114 254 Referent  0.002  40 328 Referent  0.31 
Patient genderd                  
Male 49 1,270 Referent    347 989 Referent    131 1,205 Referent   
Female 37 808 0.99 (0.98-1.01) 0.35  184 670 1.03 (0.99-1.08) 0.15  100 754 0.98 (0.95-1.01) 0.11 
Doctor specialty                  
General practice 26 1,115 Referent    - - - - -  - - - - - 
Dermatology 18 494 0.99 (0.97-1.01)   - - - - -  - - - - - 
Surgery 22 369 0.96 (0.94-0.99)   - - - - -  - - - - - 
Plastic surgery 20 100 0.86 (0.79-0.93) <0.001  - - - - -  - - - - - 
Practice setting                  
General Practitioner - - - - -  213 618 Referent    66 765 Referent   
Skin cancer clinic - - - - -  26 306 1.22 (1.15-1.29)   19 313 1.02 (0.99-1.06)  
Dermatology - - - - -  143 354 0.97 (0.91-1.04)   30 467 1.03 (0.99-1.06)  
Surgery - - - - -  88 294 1.04 (0.98-1.11)   60 322 0.95 (0.90-1.00)  
Plastic surgery - - - - -  53 74 0.80 (0.68-0.93)   46 81 0.71 (0.62-0.81)  
Melanoma unit - - - - -  8 13 0.83 (0.59-1.16) <0.001  10 11 0.62 (0.41-0.93) <0.001 
Doctor relationship                  
Primary - - - - -  - - - - -  157 1,716 Referent   
Referral - - - - -  - - - - -  74 243 0.93 (0.86-1.00) 0.04 
a This anlaysis was conducted using 2,190 questionnaires from 1,889 patients in this study. Questionnaires were excluded from multivariate analysis if they were missing values for any of the 
variables in the regression model.  
b PR = probability ratio; CI = confidence interval; estimated using log binomial regression models  
c p-value for difference between proportions across the different categories 
d Patient gender and age were included in all models regardless of statistical significance, as they were considered a priori as important covariates. Other variables were retained based on a 
cut-off p-value of 0.10, using a forward stepwise modelling approach.  
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Table 5. Multivariate model of factors associated with doctors’ management of patients regarding skin-related follow-up advice and recommendations 
Factors in order of 
entry 
Advice on skin changes given 
(n=2,022 questionnairesa)  
Encouraged skin self-examination 
(n=1,960 questionnairesa)  
Recommended skin surveillance 
(n=1,861 questionnairesa) 
No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec 
Patient aged                  
<40 18 161 1.14 (1.05-1.22)   19 154 1.22 (1.12-1.33)   31 134 1.06 (0.96-1.17)  
40-59 64 534 1.11 (1.04-1.18)   69 508 1.19 (1.10-1.28)   106 445 1.09 (1.01-1.17)  
60-79 98 807 1.13 (1.06-1.20)   122 765 1.18 (1.10-1.27)   174 656 1.08 (1.00-1.17)  
≥ 80 75 265 Referent  <0.001  106 217 Referent  <0.001  95 220 Referent  0.18 
Patient genderd                  
Male 170 1,050 Referent    199 981 Referent    245 883 Referent   
Female 85 717 1.03 (1.00-1.06) 0.08  117 663 1.01 (0.97-1.04) 0.72  161 572 0.98 (0.94-1.03) 0.40 
Patient riskd                  
Average risk 106 885 Referent    139 817 Referent    200 712 Referent   
High risk 68 602 1.01 (0.98-1.04)   80 569 1.01 (0.98-1.04)   105 501 1.04 (1.00-1.09)  
No knowledge 81 280 0.89 (0.84-0.94) <0.001  97 258 0.88 (0.83-0.94) <0.001  101 242 0.94 (0.87-1.00) 0.01 
Practice setting                  
General practice 114 650 Referent    154 594 Referent    181 517 Referent   
Skin cancer clinic 15 300 1.09 (1.05-1.13)   21 290 1.09 (1.05-1.14)   34 272 1.15 (1.09-1.23)  
Dermatology 55 409 1.03 (0.99-1.07)   63 383 1.05 (1.00-1.10)   63 348 1.12 (1.05-1.19)  
Surgery 58 285 0.99 (0.94-1.04)   62 261 1.02 (0.97-1.08)   103 211 0.95 (0.87-1.03)  
Plastic surgery 10 109 1.07 (1.02-1.12)   13 102 1.10 (1.04-1.16)   15 99 1.15 (1.06-1.26)  
Melanoma unit 3 14 0.94 (0.76-1.16) <0.001  3 14 1.00 (0.82-1.21) <0.001  10 8 0.65 (0.41-1.04) <0.001 
Doctor gender                  
Male - - - - -  - - - - -  363 1,217 Referent   
Female - - - - -  - - - - -  43 238 1.08 (1.02-1.14) 0.007 
Breslow thickness (mm)                 
0.01-1.00 - - - - -  184 1,185 Referent    250 1,032 Referent   
1.01-2.00 - - - - -  59 268 0.96 (0.92-1.01)   68 253 1.00 (0.94-1.06)  
2.01-4.00 - - - - -  40 135 0.96 (0.89-1.03)   59 111 0.88 (0.78-0.98)  
> 4.00 - - - - -  33 56 0.86 (0.75-0.99) 0.06  29 59 0.90 (0.78-1.04) 0.06 
Location of patient 
residence                 
Capital city - - - - -  - - - - -  168 712 Referent   
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Factors in order of 
entry 
Advice on skin changes given 
(n=2,022 questionnairesa)  
Encouraged skin self-examination 
(n=1,960 questionnairesa)  
Recommended skin surveillance 
(n=1,861 questionnairesa) 
No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec  No Yes PRb (95% CIb) p-valuec 
Other metropolitan - - - - -  - - - - -  72 292 1.04 (0.98-1.10)  
Large rural - - - - -  - - - - -  43 100 0.96 (0.86-1.07)  
Small rural - - - - -  - - - - -  36 165 1.04 (0.96-1.11)  
Other rural/remote - - - - -  - - - - -  87 186 0.92 (0.85-1.01) 0.10 
a This anlaysis was conducted using 2,190 questionnaires from 1,889 patients in this study. Questionnaires were excluded from multivariate analysis if they were missing values for any of the 
variables in the regression model. 
b PR = probability ratio; CI = confidence interval; estimated using log binomial regression models  
c p-value for difference between proportions across the different categories 
d Patient gender, age and patient risk were included in all models regardless of statistical significance, as they were considered a priori as important covariates. Other variables were retained 
based on a cut-off p-value of 0.10, using a forward stepwise modelling approach. 
 
